title: [Anti-pneumococcal vaccine coverage for hospitalized risk patients: Assessment and suggestions for improvements].
abstract: Streptococcus pneumoniae can cause invasive infections. Incidence and severity are linked to patients' risk factors. Due to the resistance to leading antibiotics, the anti-pneumococcal vaccination has become a major public health issue. The purpose of this survey was to evaluate the anti-pneumococcal vaccine coverage in a population of adults with risk factors. This was a prospective study that included patients with at least one recommendation for pneumococcal vaccination as indicated by the Weekly Epidemiological Bulletin (BEH), to which three further US recommendations were added (diabetes, obesity and age>65years). One hundred and thirty-four patients with an average age of 70 years were included. The physician could only confirm 68 % of the patients' vaccination status. Vaccination coverage as recommended by the BEH board was 30 % (n=54). All HIV patients were vaccinated (n=2) and the vaccination coverage was 75 % (n=8) for patients treated for autoimmune diseases and only 10 % (n=20) for patients treated with chemotherapy. Patients with no vaccination didn't know the existence of the vaccine or didn't know that vaccination was recommended to them. This study has highlighted a deficit in pneumococcal vaccination coverage and a high level of ignorance of the existence of recommended vaccination. In addition to awareness campaign for patients and caregiver training, the expansion of the vaccine e-book utilization could improve the vaccination status.
authors.affiliation: Service pharmacie, HIA Bégin, 69, avenue de Paris, 94160 Saint-Mandé, France. Electronic address: clementine.richard22@gmail.com.
authors.forename: C
authors.initials: C
authors.lastname: Richard
authors.affiliation: Service pharmacie, HIA Bégin, 69, avenue de Paris, 94160 Saint-Mandé, France.
authors.forename: P
authors.initials: P
authors.lastname: Le Garlantezec
authors.affiliation: Service pharmacie, HIA Bégin, 69, avenue de Paris, 94160 Saint-Mandé, France.
authors.forename: V
authors.initials: V
authors.lastname: Lamand
authors.affiliation: Service pharmacie, HIA Bégin, 69, avenue de Paris, 94160 Saint-Mandé, France.
authors.forename: V
authors.initials: V
authors.lastname: Rasamijao
authors.affiliation: Service des maladies infectieuses et tropicales, HIA Bégin, 69, avenue de Paris, 94160 Saint-Mandé, France.
authors.forename: C
authors.initials: C
authors.lastname: Rapp
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D005260:Female; D006760:Hospitalization; D006801:Humans; D017589:Immunization Programs / Q000706:statistics & numerical data*; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D022242:Pneumococcal Vaccines / Q000627:therapeutic use*; D011446:Prospective Studies; D058996:Quality Improvement; D012307:Risk Factors; D011795:Surveys and Questionnaires; D014611:Vaccination / Q000706:statistics & numerical data*; D055815:Young Adult
chemical_list: D022242:Pneumococcal Vaccines
keywords: At-risk patients; Couverture vaccinale; Immunization coverage; Patients à risque; Pneumococcal vaccine; Streptococcus pneumoniae; Vaccin pneumococcique